MedTrace Logo

Nasospore Stent For Use in Enodscopic Sinus Surgery

NCT00671541 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2012-02-17

No results posted yet for this study

Summary

The purpose of this study is to evaluate a stenting material called Nasopore. This is a synthetic material approved by FDA for use as a stent in postoperative sinus surgery patients. This study will compare the Nasopore stent to other approved stenting materials.

Conditions

  • Chronic Sinusitis

Interventions

DRUG

Merogel Nasal Stent and Nasopore Stent

Merogel Nasal Stent and Nasopore Stent

DRUG

Nasopore Stent and either Gentamycin or Bacitracin

Nasopore Stent with Bacitracin (100,000 units in 10cc(NSS)or Gentamycin(80mg in 10cc NSS)

Sponsors & Collaborators

  • Lahey Clinic

    lead OTHER

Principal Investigators

  • Peter J. Catalano, MD · Lahey Clinic

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-03-31
Primary Completion
2012-02-29
Completion
2012-02-29

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00671541 on ClinicalTrials.gov